Alternate means of adaptive resistance to PD-1 blockade include the expression of alternative checkpoint molecules, such as TIM-3, which appeared to be up-regulated upon tumour progression following an initial response to PD-1 blockade in human and murine samples of lung adenocarcinoma [134]. The gene discussed is HAVCR2; the disease is neoplasm.